{
    "organizations": [],
    "uuid": "bfadb26a71056d1eabcc60d57b3b08a4c8a27174",
    "author": "",
    "url": "https://www.reuters.com/article/brief-redhill-biopharma-reports-enrollme/brief-redhill-biopharma-reports-enrollment-of-300th-patient-in-confirmatory-phase-iii-study-with-talicia-idUSFWN1SB0NG",
    "ord_in_thread": 0,
    "title": "BRIEF-RedHill Biopharma Reports Enrollment of 300th Patient in Confirmatory Phase III Study With Talicia",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 4, 2018 / 11:13 AM / Updated 9 minutes ago BRIEF-RedHill Biopharma Reports Enrollment of 300th Patient in Confirmatory Phase III Study With Talicia Reuters Staff 1 Min Read\nMay 4 (Reuters) - Redhill Biopharma Ltd:\n* REDHILL BIOPHARMA ANNOUNCES ENROLLMENT OF 300TH PATIENT IN CONFIRMATORY PHASE III STUDY WITH TALICIAÂ® FOR H. PYLORI INFECTION\n* REDHILL BIOPHARMA LTD - EXPECTS TO COMPLETE ENROLLMENT IN Q3/2018 AND ANNOUNCE TOP-LINE RESULTS IN Q4/2018\n* REDHILL BIOPHARMA LTD - STUDY IS EXPECTED TO COMPLETE PACKAGE REQUIRED FOR FILING A U.S. NDA FOR TALICIA IN EARLY 2019\n* REDHILL BIOPHARMA LTD - IF ACCEPTED, TALICIA NDA WILL BENEFIT FROM PRIORITY REVIEW OF 6 MONTHS WITH POTENTIAL FDA APPROVAL IN H2/2019\n* REDHILL BIOPHARMA LTD - REMAINS ON TRACK TO POTENTIALLY COMPLETE ENROLLMENT OF ERADICATE HP2 STUDY IN Q3 OF 2018\n* REDHILL BIOPHARMA LTD - EXPECTS TO ANNOUNCE TOP-LINE RESULTS OF ERADICATE HP2 STUDY IN Q4 OF 2018 Source text for Eikon: ",
    "published": "2018-05-04T14:12:00.000+03:00",
    "crawled": "2018-05-04T14:24:29.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "biopharma",
        "report",
        "enrollment",
        "300th",
        "patient",
        "confirmatory",
        "phase",
        "iii",
        "study",
        "talicia",
        "reuters",
        "staff",
        "min",
        "read",
        "may",
        "reuters",
        "redhill",
        "biopharma",
        "ltd",
        "redhill",
        "biopharma",
        "announces",
        "enrollment",
        "300th",
        "patient",
        "confirmatory",
        "phase",
        "iii",
        "study",
        "pylorus",
        "infection",
        "redhill",
        "biopharma",
        "ltd",
        "expects",
        "complete",
        "enrollment",
        "announce",
        "result",
        "redhill",
        "biopharma",
        "ltd",
        "study",
        "expected",
        "complete",
        "package",
        "required",
        "filing",
        "nda",
        "talicia",
        "early",
        "redhill",
        "biopharma",
        "ltd",
        "accepted",
        "talicia",
        "nda",
        "benefit",
        "priority",
        "review",
        "month",
        "potential",
        "fda",
        "approval",
        "redhill",
        "biopharma",
        "ltd",
        "remains",
        "track",
        "potentially",
        "complete",
        "enrollment",
        "eradicate",
        "hp2",
        "study",
        "q3",
        "redhill",
        "biopharma",
        "ltd",
        "expects",
        "announce",
        "result",
        "eradicate",
        "hp2",
        "study",
        "q4",
        "source",
        "text",
        "eikon"
    ]
}